Gynecology & Obstetrics
Open Access

Cheng-Tao Lin

Publications

• Case Report
  Promising Tumor Remission After Immunotherapy for Late Relapse of Locally Advanced Cervical Adenocarcinoma Revealed by [18F] Fluoro-2-Deoxy-DGlucose Positron Emission Tomography
  Author(s): Hsiu-Huei Peng, Kun-Ju Lin and Cheng-Tao Lin Hsiu-Huei Peng, Kun-Ju Lin and Cheng-Tao Lin
  
  The prognosis of patients with metastatic cervical cancer is poor, with a median survival of 8-13 months. Treatment with chemotherapeutic drugs alone is rarely curative. In the past few years, the development of immunotherapy, targeted therapy, angiogenesis inhibitors, and tyrosine kinase inhibitors has provided better treatment choices for patients with metastatic cervical cancer. A 52-year-old woman was diagnosed on July 2001, with locally advanced adenocarcinoma of cervix, stage IIb. She underwent concurrent chemoradiotherapy resulting in complete remission for over 10 years. Unfortunately, she was found to have a late relapse of cervical adenocarcinoma with liver metastases (segments 7 and 8) on June 2013. She underwent segmental hepatectomy and cholecystectomy and was transferred to our gynecologic oncology service for standard chemotherapy with immunotherapy based on h.. View More»
  DOI: 10.4172/2161-0932.1000395

  Abstract PDF

Relevant Topics